CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Return
34.55%
This Quarter Return
+12.95%
1 Year Return
+34.55%
3 Year Return
+41.71%
5 Year Return
+124.92%
10 Year Return
+254.42%
AUM
$134B
AUM Growth
+$23.2B
(+21%)
Cap. Flow
+$6.38B
Cap. Flow
% of AUM
4.76%
Top 10 Holdings %
Top 10 Hldgs %
17.29%
Holding
3,686
New
384
Increased
2,023
Reduced
847
Closed
166
Top Buys
| 1 |
Baidu
BIDU
|
+$769M |
| 2 |
Tencent Music
TME
|
+$761M |
| 3 |
Alibaba
BABA
|
+$708M |
| 4 |
Tesla
TSLA
|
+$656M |
| 5 |
Amazon
AMZN
|
+$399M |
Top Sells
| 1 |
UnitedHealth
UNH
|
+$571M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$324M |
| 3 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$260M |
| 4 |
Bank of America
BAC
|
+$222M |
| 5 |
ETFC
E*Trade Financial Corporation
ETFC
|
+$205M |
Sector Composition
| 1 | Technology | 20.57% |
| 2 | Consumer Discretionary | 14.31% |
| 3 | Healthcare | 14.06% |
| 4 | Communication Services | 10.76% |
| 5 | Financials | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MTOR
2001
DELISTED
MERITOR, Inc.
MTOR
| $2.18M | ﹤0.01% |
78,261
+14,288
| +22% | +$399K |
|
2002
Veritex Holdings
VBTX
$1.88B
| $2.18M | ﹤0.01% |
84,996
+17,082
| +25% | +$438K |
|
|
EPZM
2003
DELISTED
Epizyme, Inc
EPZM
| $2.18M | ﹤0.01% |
200,712
+28,159
| +16% | +$306K |
|
2004
Rocket Companies
RKT
$44.4B
| $2.18M | ﹤0.01% |
107,785
+97,723
| +971% | +$1.98M |
|
2005
Rush Street Interactive
RSI
$2.02B
| $2.18M | ﹤0.01% |
+100,614
| New | +$2.18M |
|
|
UFS
2006
DELISTED
DOMTAR CORPORATION (New)
UFS
| $2.18M | ﹤0.01% |
68,782
-160,311
| -70% | -$5.08M |
|
2007
New Fortress Energy
NFE
$373M
| $2.18M | ﹤0.01% |
+40,631
| New | +$2.18M |
|
2008
MacroGenics
MGNX
$100M
| $2.17M | ﹤0.01% |
94,938
+9,384
| +11% | +$214K |
|
2009
Lindsay Corp
LNN
$1.52B
| $2.17M | ﹤0.01% |
16,870
+3,591
| +27% | +$461K |
|
|
GMS
2010
DELISTED
GMS Inc
GMS
| $2.16M | ﹤0.01% |
70,973
+13,813
| +24% | +$421K |
|
2011
Cheesecake Factory
CAKE
$2.82B
| $2.16M | ﹤0.01% |
58,311
+17,899
| +44% | +$663K |
|
2012
ImmunityBio
IBRX
$2.46B
| $2.15M | ﹤0.01% |
161,583
+126,192
| +357% | +$1.68M |
|
2013
Outfront Media
OUT
$3.16B
| $2.15M | ﹤0.01% |
111,723
+6,067
| +6% | +$117K |
|
2014
Arcturus Therapeutics
ARCT
$470M
| $2.15M | ﹤0.01% |
49,531
-26,030
| -34% | -$1.13M |
|
2015
Atkore
ATKR
$2.06B
| $2.15M | ﹤0.01% |
52,233
+9,307
| +22% | +$383K |
|
2016
ProShares MSCI Transformational Changes ETF
ANEW
$7.75M
| $2.14M | ﹤0.01% |
+50,750
| New | +$2.14M |
|
2017
City Holding Co
CHCO
$1.83B
| $2.14M | ﹤0.01% |
30,810
+3,036
| +11% | +$211K |
|
2018
Esperion Therapeutics
ESPR
$573M
| $2.14M | ﹤0.01% |
82,451
-912,963
| -92% | -$23.7M |
|
2019
iShares MSCI Philippines ETF
EPHE
$103M
| $2.14M | ﹤0.01% |
65,505
-12,561
| -16% | -$411K |
|
2020
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.17B
| $2.14M | ﹤0.01% |
57,015
+41,937
| +278% | +$1.58M |
|
2021
Westlake Corp
WLK
$11.3B
| $2.14M | ﹤0.01% |
26,197
-1,653
| -6% | -$135K |
|
2022
Plains GP Holdings
PAGP
$3.7B
| $2.13M | ﹤0.01% |
252,578
+85,435
| +51% | +$722K |
|
2023
Relay Therapeutics
RLAY
$688M
| $2.13M | ﹤0.01% |
+51,223
| New | +$2.13M |
|
2024
TransAlta
TAC
$3.75B
| $2.12M | ﹤0.01% |
279,908
+3,437
| +1% | +$26.1K |
|
2025
Smith & Wesson
SWBI
$415M
| $2.12M | ﹤0.01% |
119,153
+15,800
| +15% | +$280K |
|